Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Introducing our Latest IPC Councilors: Experts in Psoriasis Treatment and Research

Join us in welcoming IPC’s newest Councilors, Marwa Amer, Paola Di Meglio, Albert Duvetorp, Melinda Gooderham, Chih-Hung Lee, Xiao-Yong Man, and Juul van den Reek. This group of experts was recently appointed and selected by the IPC Board of Directors for their dedication to enhancing global research on psoriasis and improving patient care.

As IPC Councilors, they will use their invaluable expertise to better IPC initiatives and help advance psoriasis research, treatment, and education on a global scale. We encourage you to learn more about this group of psoriasis experts through their comprehensive biographies.

Let’s extend a warm welcome to Marwa Amer, Paola Di Meglio, Albert Duvetorp, Melinda Gooderham, Chih-Hung Lee, Xiao-Yong Man, and Juul van den Reek as members of the IPC Councilor community, underscoring IPC’s commitment to driving positive change and improvement in global psoriasis care.

Marwa Amer, MD, PhD

Kasr Al-Ainy Hospital, Cairo University

Cairo, Egypt

IPC Councilor

Bio

Paola Di Meglio, PhD

King’s College London

London, United Kingdom

IPC Councilor

Bio

Albert Duvetorp, MD, PhD

Skåne University Hospital

Malmö, Sweden

IPC Councilor

Bio

Melinda Gooderham, MSc, MD, FRCPC

SKiN Centre for Dermatology

Peterborough, Ontario, Canada

IPC Councilor

Bio

Chih-Hung Lee , MD, PhD

Kaohsiung Chang Gung Memorial Hospital

Kaohsiung, Taiwan

IPC Councilor

Bio

Xiao-Yong Man, MD, PhD

The Second Affiliated Hospital Zhejiang University School of Medicine

Hangzhou, China

IPC Councilor

Bio

Juul van den Reek, MD, PhD

Radboud University Medical Center

Nijmegen, Netherlands

IPC Councilor

Bio

Categories

Recent Posts

What Comes Next in Psoriasis Treatment: A Look at the Current Pipeline

When Cancer and Psoriasis Coexist: New IPC Guidance Puts Clarity Where It Is Needed Most

Reframing Obesity in Psoriatic Disease: From Pharmacokinetic Barrier to Therapeutic Target

Also Read

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.

What's New

Psoriasis: An Expert Global Perspective Is Now Available for Pre-Order

IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.

PRE-ORDER YOUR COPY

Thursday, September 10, 2026

New Video Resource: Early Diagnosis and Treatment of Psoriatic Arthritis (PsA)

In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.

WATCH NOW

Friday, September 25, 2026

Take Ten Video: Bridging Psoriasis and Metabolic Comorbidities

IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.

WATCH NOW

Wednesday, September 9, 2026